Scarica l'app Stockscreener
0.534
9.49%
-0.056
Dopo l'orario di chiusura:
.54
0.006
+1.12%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Prophase Labs Inc Borsa (PRPH) Ultime notizie
ProPhase Labs Appoints Stuart Hollenshead as COO - TipRanks
ProPhase Labs Announces Excellent Progress with Crown - GlobeNewswire
ProPhase Labs Targets Immediate Cash Generation With COVID-19 Receivables And Asset Sales - Nasdaq
Can ProPhase Labs Transform $150M in COVID Claims into a $50M Windfall? - StockTitan
ProPhase Labs hires Stuart Hollenshead as COO - TipRanks
ProPhase Labs appoints Stu Hollenshead as COO By Investing.com - Investing.com Nigeria
ProPhase Labs hires Stuart Hollenshead as COO, the former COO and CBO of Barstool Sports - GlobeNewswire
ProPhase Labs Appoints Stu Hollenshead as Chief Operating Officer -February 18, 2025 at 09:45 am EST - Marketscreener.com
ProPhase Labs shares rise on cost cutting plans, hires former Barstool Sports COO Stu Hollenshead - Seeking Alpha
ProPhase Labs appoints Stu Hollenshead as COO - Investing.com
Barstool Sports Executive Powerhouse Joins ProPhase Labs: Major Push into 70M Women Health Market - StockTitan
ProPhase Labs (NASDAQ:PRPH) Now Covered by StockNews.com - Defense World
ProPhase Labs FY2024 EPS Estimate Reduced by Diamond Equity - Defense World
ProPhase Labs Stock Hits 52-Week Low at $0.56 Amid Market Struggles - MSN
ProPhase Labs Appoints New Chief Operating Officer - TipRanks
ProPhase Labs appoints new COO amid executive changes By Investing.com - Investing.com South Africa
ProPhase Labs appoints new COO amid executive changes - MSN
StockNews.com Begins Coverage on ProPhase Labs (NASDAQ:PRPH) - Defense World
Following A -1.03% Weekly Decline, Is It Still A Buy For ProPhase Labs Inc (NASDAQ: PRPH)? - Marketing Sentinel
ProPhase Labs Inc [PRPH] moved up 1.41: Why It’s Important - The DBT News
PRPH’s Q2 earnings predictions: What the experts say - US Post News
ProPhase Labs Enters into Common Stock Purchase Agreement with Equity Line Investor - Defense World
ProPhase Labs (NASDAQ:PRPH) Coverage Initiated by Analysts at StockNews.com - Defense World
ProPhase Labs stock hits 52-week low at $0.41 amid sharp decline - MSN
ProPhase Labs, Inc. (PRPH) Reports Q3 Loss, Tops Revenue Estimates - MSN
StockNews.com Initiates Coverage on ProPhase Labs (NASDAQ:PRPH) - Defense World
ProPhase Labs Announces Closing of $23.6 Million Sale of - GlobeNewswire
An undisclosed buyer acquired Pharmaloz Manufacturing Inc. and Pharmaloz Real Estate Holdings, Inc. from ProPhase Labs, Inc. for approximately $23.6 million. - Marketscreener.com
ProPhase Labs Stock Hits 52-Week Low at $0.56 Amid Market Struggles By Investing.com - Investing.com South Africa
ProPhase Labs Closes $23.6 Million Sale of Pharmaloz Manufacturing to Houston-Based Private Equity Firm - citybiz
ProPhase Labs Announces Closing of $23.6 Million Sale of Pharmaloz Manufacturing to Houston-Based Private Equity Firm - The Manila Times
ProPhase Labs Sells Manufacturing Units for $23.6M, Eliminates $20M in Debt in Strategic Sale - StockTitan
PRPH (ProPhase Labs) 3-Year Book Growth Rate : 44.30% (As of Sep. 2024) - GuruFocus.com
PRPH (ProPhase Labs) Debt-to-EBITDA : -1.36 (As of Sep. 2024) - GuruFocus.com
ProPhase Labs stock hits 52-week low at $0.61 amid sharp decline - Investing.com Canada
ProPhase Labs Receives Notice from NASDAQ Regarding Minimum Bid Price Requirement On December 26, 2024, ProPhase Labs, Inc. (NASDAQ: PRPH) received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC, indicating that t - Defense World
ProPhase Labs faces potential Nasdaq delisting over share price By Investing.com - Investing.com Nigeria
ProPhase Labs faces potential Nasdaq delisting over share price - Investing.com
HighTower Advisors LLC Boosts Stock Position in ProPhase Labs, Inc. (NASDAQ:PRPH) - Defense World
ProPhase Labs stock hits 52-week low at $0.64 amid sharp decline - Investing.com Australia
ProPhase Labs stock hits 52-week low at $0.64 amid sharp decline By Investing.com - Investing.com South Africa
ProPhase Labs stock hits 52-week low at $0.66 amid sharp decline By Investing.com - Investing.com South Africa
ProPhase Labs stock hits 52-week low at $0.66 amid sharp decline - Investing.com
ProPhase Labs secures private equity backing, nears lozenge deal, and plans cost-cutting measures - MSN
ProPhase Labs Secures Global Private Equity Backing, Nears Major Lozenge Deal, Adds Seasoned Industry Expert, and Plans Significant Cost-Cutting Measures - The Manila Times
ProPhase Labs Secures Global Private Equity Backing, Nears - GlobeNewswire
ProPhase Labs Secures Game-Changing Financing Deal, Eyes Major Asian Market Expansion - StockTitan
0.06%
3.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):